Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Zimbus Breezhaler

Authorised

Human

Details

EMA number	EMEA/H/C/005518
ATC code	R03AL
Authorisation	3 July 2020
Revision	8

Therapeutic indication

Maintenance treatment of asthma in adults whose disease is not adequately controlled.

MeSH: Asthma

Group: Drugs for obstructive airway diseases

Active substances

glycopyrronium bromide indacaterol acetate mometasone furoate

Marketing Authorisation Holder

Novartis Europharm Limited

Timeline

Filter by authority:

Zimbus Breezhaler authorised

3 Jul 2020

authorisedregulatory

Zimbus Breezhaler | uMedical